2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole has been researched along with beta-funaltrexamine in 1 studies
| Studies (2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole) | Trials (2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole) | Recent Studies (post-2010) (2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole) | Studies (beta-funaltrexamine) | Trials (beta-funaltrexamine) | Recent Studies (post-2010) (beta-funaltrexamine) |
|---|---|---|---|---|---|
| 14 | 0 | 2 | 542 | 1 | 54 |
| Protein | Taxonomy | 2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole (IC50) | beta-funaltrexamine (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.082 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.082 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.082 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.082 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.082 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bykov, V; Holaday, JW; Jacobson, AE; Long, JB; Rice, KC; Rothman, RB | 1 |
1 other study(ies) available for 2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole and beta-funaltrexamine
| Article | Year |
|---|---|
Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptors.
Topics: Animals; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; In Vitro Techniques; Isothiocyanates; Kinetics; Naltrexone; Narcotic Antagonists; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Thiocyanates; Up-Regulation | 1990 |